Pro Medicus (ASX:PME) Insider Peter Kempen Purchases 400 Shares

Pro Medicus Limited (ASX:PME) insider Peter Kempen acquired 400 shares of the firm’s stock in a transaction dated Monday, February 23rd. The shares were purchased at an average price of A$116.43 per share, for a total transaction of A$46,572.00.

Peter Kempen also recently made the following trade(s):

• On Monday, December 29th, Peter Kempen acquired 600 shares of Pro Medicus stock. The shares were bought at an average cost of A$224.00 per share, with a total value of A$134,400.00.

Pro Medicus Stock Performance

The company has a market cap of $29.16 billion, a P/E ratio of 351.99, a P/E/G ratio of 3.87 and a beta of 0.56. The company has a quick ratio of 4.39, a current ratio of 5.98 and a debt-to-equity ratio of 1.10.

Pro Medicus Announces Dividend

The firm also recently disclosed a Interim dividend, which will be paid on Thursday, March 19th. Shareholders of record on Thursday, March 19th will be paid a $0.32 dividend. This represents a dividend yield of 27.0%. The ex-dividend date of this dividend is Wednesday, February 25th. Pro Medicus’s dividend payout ratio (DPR) is presently 56.41%.

About Pro Medicus

Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers Visage radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products.